DBV Technologies S.A. (DBVT) Financials

DBVT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 266.4 million 58.4 million
Dec. 31, 2025 233.7 million 64.9 million
Sept. 30, 2025 110.5 million 57.6 million
June 30, 2025 143.4 million 57.2 million

DBVT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -49.1 million 2.3 million
Dec. 31, 2025 -35.6 million 1.9 million
Sept. 30, 2025 -32.6 million 516000
June 30, 2025 -33.9 million 1.2 million

DBVT Net Income

No data available :(

DBVT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 229.2 million - 6.1 million
Dec. 31, 2025 194.2 million - 5.4 million
Sept. 30, 2025 69.8 million - 6.7 million
June 30, 2025 103.2 million - 7.7 million

DBVT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 85.7 trillion
Dec. 31, 2025 7.7 million
Sept. 30, 2025 19.2 million
June 30, 2025 19.2 million

DBVT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 400000 33.4 million 5.7 million -4.8 million
Dec. 31, 2025 379000 32.9 million 11.3 million -
Sept. 30, 2025 117000 26.8 million 5.8 million 519000
June 30, 2025 32000 31.6 million 7.7 million -986000

DBVT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - 4.3 million
Sept. 30, 2025 - 4.3 million
June 30, 2025 - 4.6 million

DBVT

Price: $13.63

52 week price:
8.51
26.19

Earnings Per Share: -5.11 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 78800

Ebitda: -157.7 million

Market Capitalization: 378.4 million

Links: